Pfizer balance sheet

As of Mar 2026

Total assets: ₹4,922cr+0.2% on Mar 2025
Shareholders' equity: ₹4,203cr−0.3% on Mar 2025
Total debt: ₹2.5cr0.0% on Mar 2025
Cash and investments: ₹103cr−79.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	136	172	151	178
	20.0	7.6	0.4	7.9
	—	—	—	28.2
	527	527	527	527
	14.4	24.3	34.3	—
	—	—	—	0.4
	15.2	13.9	14.3	13.0
	72.3	69.3	53.9	97.7
	—	166	214	183
	1,119	1,398	1,459	1,476
	473	476	434	418
	182	193	188	152
	103	495	112	1,823
	3,008	2,306	1,935	1,823
	—	—	—	0.3
	3.0	3.9	13.0	23.0
	3,296	2,998	2,247	2,034
	35.0	39.0	56.8	41.4
	3,803	3,513	2,738	2,493
	4,922	4,911	4,229	4,001
Equity
	45.8	45.8	45.8	45.8
	4,157	4,172	3,550	3,162
	4,203	4,217	3,596	3,207
	4,203	4,217	3,596	3,207
Liabilities
	48.1	56.6	32.3	42.8
	91.5	124	86.7	136
	2.5	2.5	2.5	2.5
	—	—	5.5	−38.1
	—	—	37.5	63.5
	30.3	51.3	45.0	101
	232	221	160	161
	45.6	64.8	97.6	—
	627	570	547	657
	719	694	633	793
	4,922	4,911	4,229	4,001

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PFIZER₹3,734.40

Pfizer Ltd.

· Pharma & Health

₹ CrorePeersGLAXO ABBOTINDIA POLYMED ONESOURCE RAINBOW KIMS JUBLPHARMA VIJAYA

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	177.5	151.0	171.8	136.1	136.1
+ Capital Work-in-Progress	7.9	0.4	7.6	20.0	20.0
+ Investment Property	28.2	—	—	—	—
+ Goodwill	527.5	527.5	527.5	527.5	527.5
+ Other Intangibles	—	34.3	24.3	14.4	14.4
+ Long-term Loans	0.4	—	—	—	—
+ Other Non-current Financial Assets	13.0	14.3	13.9	15.2	15.2
+ Deferred Tax Assets	97.7	53.9	69.3	72.3	72.3
+ Other Non-current Assets	182.9	213.7	166.5	—	—
Total Non-current Assets	1,475.6	1,459.2	1,398.3	1,118.7	1,118.7
Current Assets
+ Inventories	417.7	433.7	475.9	472.7	472.7
+ Trade Receivables	151.7	187.6	193.1	181.8	181.8
+ Cash & Cash Equivalents	1,822.9	112.0	495.1	102.7	102.7
+ Other Bank Balances	1,822.9	1,934.7	2,305.9	3,008.1	3,008.1
+ Short-term Loans	0.3	—	—	—	—
+ Other Current Financial Assets	23.0	13.0	3.9	3.0	3.0
Current Financial Assets	2,034.2	2,247.3	2,998.0	3,295.5	3,295.5
+ Other Current Assets	41.4	56.8	39.0	35.0	35.0
Total Current Assets	2,493.3	2,737.8	3,512.9	3,803.2	3,803.2
Total Assets	4,000.7	4,228.8	4,911.1	4,921.9	4,921.9
Equity
+ Equity Share Capital	45.8	45.8	45.8	45.8	45.8
+ Other Equity / Reserves	3,161.6	3,549.8	4,171.7	4,157.2	4,157.2
Equity — Owners of Parent	3,207.3	3,595.5	4,217.4	4,202.9	4,202.9
Total Equity	3,207.3	3,595.5	4,217.4	4,202.9	4,202.9
Liabilities
+ Provisions — Non-current	42.8	32.3	56.6	48.1	48.1
Non-current Liabilities	136.1	86.7	124.2	91.5	91.5
+ Borrowings — Current	2.5	2.5	2.5	2.5	2.5
+ Trade Payables	-38.1	5.5	—	—	—
+ Other Current Financial Liab	63.5	37.5	—	—	—
+ Provisions — Current	100.5	45.0	51.3	30.3	30.3
+ Current Tax Liabilities	160.8	160.1	221.0	232.0	232.0
+ Other Current Liabilities	—	97.6	64.8	45.6	45.6
Current Liabilities	657.4	546.6	569.5	627.5	627.5
Total Liabilities	793.4	633.2	693.7	719.0	719.0
Total Equity & Liabilities	4,000.7	4,228.8	4,911.1	4,921.9	4,921.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.